Obstructive sleep apnea (OSA) is characterized by recurrent episodes of complete or partial collapse of the pharyngeal airway, resulting in airflow limitation and disrupted sleep architecture through repeated short awakening periods. Recent reports have suggested an association between chronic cough and OSA, but little is known about the association of OSA with hemoptysis. The repetitive upper airway obstruction during sleep is the hallmark of OSA. Consequently, untreated OSA can perpetuate chronic cough and eventually lead to non-massive hemoptysis. Common causes for chronic cough in nonsmokers with normal chest radiographs include upper airway cough syndrome, gastroesophageal reflux disease, and cough-variant asthma. We present a case of cough-related OSA and hemoptysis, which was previously diagnosed and treated as cough-variant asthma. The initiation of nocturnal continuous positive airway pressure (CPAP) resulted not only in the resolution of sleep apneas and hypopneas but also in the resolution of the chronic cough and hemoptysis.
This is a case of a 61-year-old woman who presented with a 6month history of cough and bloody sputum predominantly in the morning. Her past medical history was significant for asthma well controlled with inhalers until 6 months prior to her presentation. She was on prednisone for uncontrolled asthma symptoms and as a result gained over 35 pounds. During this time, the patient referred symptoms that were consistent with obstructive sleep apnea (OSA) and underwent a polysomnogram, which revealed very severe OSA with an Apnea-Hypopnea Index (AHI) of 71 events per hour. The chest roentgenogram was unremarkable, and complete workup for underlying coagulopathy was negative. Nasolaryngoscopy was completed and did not show abnormalities in the nasal passages or oral cavity. Additionally, the patient denied any history or symptoms of gastroesophageal reflux disease.
A flexible bronchoscopy was performed prior to the initiation of continuous positive airway pressure (CPAP), to further investigate the etiology of the hemoptysis. This revealed a thick, well-demarcated band of petechiae and ecchymosis in the cervical trachea ( Fig. 1 ); no endobronchial lesions were visualized. The patient was initiated on CPAP therapy for OSA, and a follow-up bronchoscopy after 5 weeks of treatment revealed complete resolution of the petechial band ( Fig. 2 ) and resolution of the hemoptysis. Hemoptysis is a sign of many different underlying etiologies ranging from bronchial infections to malignancy. The most common cause is typically the least serious, usually a ruptured small blood vessel caused by excessive coughing during a respiratory tract infection. Repetitive upper airway obstruction events during sleep are the hallmark of OSA, and the frequency of these events is what determines the severity of the disease.
Functional magnetic resonance imaging (MRI) can provide an excellent evaluation of the various anatomical planes of the sites of upper airway obstruction in patient with OSA and eventually demonstrates that incremental levels of continuous positive airway pressure (CPAP) result in progressive thinning of the lateral pharyngeal walls.
It is also believed that OSA perpetuates chronic cough, which can lead to hemoptysis. This theory is based on reports of improvement in the cough after initiation and compliance of nocturnal CPAP for sleep apnea [1] . The effect of positive pressure therapy on hemoptysis is largely unknown, and the mechanism may lie in the effect it has on airway inflammation. Baessler et al. showed that sleep apnea treatment with CPAP improves the levels of inflammatory markers as evidence by reductions in CRP, IL-6, and TNFα [2] .
Another theory has suggested that alterations induced by vibration triggers a pro-inflammatory cascade in the bronchial epithelial cells [3] . A recent rat model has shown that snoringlike vibration triggers this early inflammatory response in the soft palate [3] . The belief is that, as with snoring, chronic cough can lead to this inflammatory response making the bronchial cells more susceptible to rupture and petechiae as shown on bronchoscopy.
Research has demonstrated the benefits of continuous positive airway pressure in treating disorders such as obstructive sleep apnea. CPAP is currently the most widely used form of NIPPV and applies a constant level of positive pressure in the airway during spontaneous breathing [4] . CPAP splints the alveoli open, thereby preventing alveolar collapse and allowing unimpeded alveolar ventilation. Furthermore, titration studies with CPAP are aimed at opening the collapsible segment of the airways. CPAP improves lung compliance, increases functional residual capacity and daytime gas exchange, and decreases the work of breathing [4] .
Cough is frequently encountered in patients with OSA, and OSA prevalence appears to be high in patients with chronic cough [1] . The airway inflammation and petechial band in our patient most likely resulted from her uncontrolled OSA and cough [5] . Similar to our case presentation, Uyar et al. described in their article the significant proportion of patients presenting with hemoptysis with high risk for OSA. And furthermore, the patients at high risk for OSA were more predisposed to have massive hemoptysis [6] .
CPAP therapy in patients with OSA increases the amount of restorative sleep thereby improving disease-related injury and inflammation of the respiratory tract [1] . In other words, by decreasing the number of apneic/hypopneic episodes, we effectively decrease the recurrent trauma to the patient's airways and limit the likelihood of hemoptysis.
In conclusion, chronic cough is a common cause for nonmassive hemoptysis in patients with OSA, and CPAP therapy has shown to help alleviate the symptoms. Underlying OSA should be considered in the differential diagnosis of nonmassive hemoptysis, and flexible bronchoscopy prior to initiating CPAP is warranted.
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